Type1_Research_Developments
CMTAUSA.ORG over, please Demyelinating CMT: Type 1, Type X and Type 4 Research Developments In a multipronged approach to identifying novel treatments for demyelinating CMT, the CMTA is pursuing several…
CELEBRATING 2023
…and committed investments of $5,000,00 in research dedicated to finding effective treatments and ultimately a cure for Charcot-Marie-Tooth disease. Support for Natural History Studies Drives Clinical Trial Readiness: In 2023,…